Watchlist Manager

Watchlist

Price: 4 105 KRW 1.36%

Market Cap: ₩45.2B

K	Korean Drug Co Ltd KOSDAQ:014570	KR
	Ufp Industries Inc NASDAQ:UFPI	US
M	Medtecs International Corporation Ltd SGX:546	TW
M	Multicell Technologies Inc OTC:MCET	US
V	Viohalco SA ATHEX:VIO	BE
S	Solar A/S XBER:ZVR	DK
	UMB Financial Corp NASDAQ:UMBF	US
R	Rigetti Computing Inc NASDAQ:RGTI	US
	Zenith Minerals Ltd ASX:ZNC	AU
	Chubb Ltd NYSE:CB	CH
O	Orient Electric Ltd NSE:ORIENTELEC	IN
	Genmab A/S CSE:GMAB	DK
S	SMC Trading Investment JSC VN:SMC	VN
	Risanamento SpA MIL:RN	IT
	Shanghai Commercial & Savings Bank Ltd TWSE:5876	TW
	Red Robin Gourmet Burgers Inc NASDAQ:RRGB	US
	Domo Inc NASDAQ:DOMO	US
	Applied BioCode Corp TWSE:6598	TW
M	MTI Investment SE STO:MTI	SE

Balance Sheet

Currency: KRW

	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	1 273	969	1 360	2 047	1 455	1 951	1 853	1 446	1 568	2 099	2 338	3 256	3 268	3 219	3 146	2 397	5 480	6 270	7 068	4 841	3 426	11 689	4 103	4 886
Cash	0	0	0	0	0	0	0	0	0	0	1 237	1 282	934	0	0	0	0	165	163	165	182	115	38	38
Cash Equivalents	1 273	969	1 360	2 047	1 455	1 951	1 853	1 446	1 568	2 099	1 101	1 974	2 334	3 219	3 146	2 397	5 480	6 105	6 905	4 677	3 244	11 574	4 066	4 847
Short-Term Investments	784	932	534	731	577	622	40	51	46	41	30	16	5	350	848	753	3 141	5 255	15 162	23 039	22 990	5 067	14 897	25 111
Total Receivables	21 356	22 658	23 299	25 030	25 162	26 855	27 801	30 360	36 805	38 261	36 207	32 362	31 007	26 659	32 334	36 099	32 891	28 080	27 894	28 983	31 460	28 008	22 891	23 167
Accounts Receivables	21 225	22 480	23 201	24 958	24 962	26 736	27 681	30 277	36 709	38 078	36 110	32 300	30 985	26 640	32 317	36 059	32 877	28 040	27 880	28 501	31 196	27 854	22 813	23 142
Other Receivables	131	178	98	72	200	119	120	83	96	183	97	62	22	19	17	40	14	40	14	482	264	154	78	26
Inventory	3 340	3 422	3 466	3 383	4 164	4 528	5 797	6 454	7 737	7 206	8 554	8 823	9 540	9 918	8 318	9 074	9 383	11 839	10 744	12 894	13 775	18 341	20 168	15 526
Other Current Assets	119	50	56	689	692	836	652	831	207	197	394	135	128	290	276	408	39	90	2 087	693	965	321	867	376
Total Current Assets	26 871	28 031	28 716	31 881	32 051	34 792	36 143	39 142	46 363	47 804	47 524	44 591	43 947	40 437	44 922	48 730	50 935	51 535	62 956	70 450	72 617	63 426	62 925	69 066
PP&E Net	12 762	13 372	12 844	12 481	12 661	13 203	13 736	15 049	16 479	16 399	16 144	15 580	15 223	14 919	14 565	14 878	12 630	14 849	13 784	13 999	18 607	22 999	22 054	20 653
PP&E Gross	12 762	13 372	12 844	12 481	12 661	13 203	13 736	15 049	16 479	16 399	16 144	15 580	15 223	0	0	0	12 630	14 849	13 784	13 999	18 607	22 999	22 054	20 653
Accumulated Depreciation	3 540	4 396	5 214	5 891	6 493	7 338	8 242	8 955	8 647	9 665	10 554	11 467	12 362	0	0	0	15 584	16 356	17 566	18 291	19 158	19 934	21 558	23 263
Intangible Assets	256	63	29	31	29	22	29	84	653	647	311	294	757	892	796	834	758	661	684	274	502	374	220	220
Note Receivable	190	189	222	206	181	285	577	622	481	561	0	0	0	1 163	837	715	0	0	0	0	0	0	0	0
Long-Term Investments	166	159	199	34	62	682	682	952	1 247	1 247	1 283	1 283	860	1 219	1 694	706	5 429	5 514	3 402	2 140	1 303	1 040	1 296	1 111
Other Long-Term Assets	0	0	0	0	0	0	197	160	133	24	680	1 793	1 387	567	597	930	3 210	3 291	2 519	1 749	1 488	1 870	2 393	3 270
Total Assets	40 246 N/A	41 814 +4%	42 008 +0%	44 632 +6%	44 983 +1%	48 983 +9%	51 363 +5%	56 009 +9%	65 356 +17%	66 682 +2%	65 943 -1%	63 542 -4%	62 175 -2%	59 197 -5%	63 411 +7%	66 794 +5%	72 962 +9%	75 850 +4%	83 345 +10%	88 613 +6%	94 516 +7%	89 709 -5%	88 887 -1%	94 318 +6%
Liabilities
Accounts Payable	1 041	1 697	1 556	1 834	1 923	1 656	1 493	2 111	2 511	2 490	2 882	2 245	2 649	3 247	4 750	4 347	2 663	3 066	2 662	3 213	5	1 921	570	1 243
Accrued Liabilities	655	584	619	801	753	926	813	759	1 161	1 063	967	1 205	1 041	0	0	0	1 759	1 843	1 934	2 313	2 869	2 768	2 856	3 018
Short-Term Debt	9 200	9 200	8 700	8 000	6 000	5 500	7 049	9 386	12 224	10 600	10 500	7 000	4 000	1 000	500	500	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	56	0	0	0	0	0	0	0	0	0	0	0	500	1 500	0	500	0	54	46	39	59	51	63	43
Other Current Liabilities	1 004	396	807	1 151	919	1 798	677	299	914	727	266	460	1 116	1 560	2 784	3 255	2 139	1 560	5 130	4 764	4 479	5 162	3 721	3 987
Total Current Liabilities	11 956	11 877	11 681	11 786	9 595	9 880	10 032	12 555	16 810	14 880	14 614	10 909	9 307	7 308	8 034	8 602	6 561	6 523	9 771	10 329	7 412	9 902	7 210	8 292
Long-Term Debt	0	0	0	0	0	0	0	0	2 000	2 000	1 000	3 000	2 000	500	500	0	0	26	6	15	22	16	18	15
Deferred Income Tax	687	664	63	330	174	104	0	0	208	234	134	216	110	145	0	0	237	11	0	0	0	0	0	0
Other Liabilities	1 754	1 654	2 177	1 985	2 217	2 494	2 356	2 350	2 095	2 598	2 620	1 994	1 967	1 567	1 216	1 218	3 364	4 240	2 697	1 579	2 370	2 701	3 553	2 941
Total Liabilities	14 397 N/A	14 195 -1%	13 921 -2%	14 101 +1%	11 987 -15%	12 478 +4%	12 388 -1%	14 905 +20%	21 112 +42%	19 712 -7%	18 368 -7%	16 119 -12%	13 384 -17%	9 519 -29%	9 749 +2%	9 821 +1%	10 163 +3%	10 800 +6%	12 474 +16%	11 923 -4%	9 804 -18%	12 619 +29%	10 781 -15%	11 247 +4%
Equity
Common Stock	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500	5 500
Retained Earnings	13 968	15 695	16 182	18 619	21 091	24 567	27 091	29 219	35 338	38 064	38 668	38 687	40 089	41 025	45 087	48 456	54 307	56 636	62 488	69 345	77 364	69 724	70 591	75 529
Additional Paid In Capital	3 407	3 407	3 407	3 407	3 407	3 407	3 407	3 407	3 407	3 407	3 407	3 407	3 407	3 154	3 049	3 057	3 407	3 407	3 407	3 407	3 407	3 407	3 407	3 407
Unrealized Security Profit/Loss	3 512	3 556	3 537	3 544	3 536	3 569	3 512	3 512	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	170	205	0	0	0	419	499	536	1 586	1 583	1 563	1 360	1 323
Other Equity	538	538	538	538	538	538	534	534	0	0	0	0	0	0	26	40	5	7	12	24	24	23	32	41
Total Equity	25 849 N/A	27 619 +7%	28 088 +2%	30 531 +9%	32 997 +8%	36 505 +11%	38 975 +7%	41 104 +5%	44 245 +8%	46 970 +6%	47 575 +1%	47 423 0%	48 791 +3%	49 679 +2%	53 662 +8%	56 973 +6%	62 799 +10%	65 050 +4%	70 871 +9%	76 690 +8%	84 713 +10%	77 090 -9%	78 106 +1%	83 072 +6%
Total Liabilities & Equity	40 246 N/A	41 814 +4%	42 008 +0%	44 632 +6%	44 983 +1%	48 983 +9%	51 363 +5%	56 009 +9%	65 356 +17%	66 682 +2%	65 943 -1%	63 542 -4%	62 175 -2%	59 197 -5%	63 411 +7%	66 794 +5%	72 962 +9%	75 850 +4%	83 345 +10%	88 613 +6%	94 516 +7%	89 709 -5%	88 887 -1%	94 318 +6%
Shares Outstanding
Common Shares Outstanding	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11	11

Income Statement Balance Sheet Cash Flow Statement

Korean Drug Co Ltd
KOSDAQ:014570

Balance Sheet

Balance Sheet Decomposition
Korean Drug Co Ltd

Balance Sheet
Korean Drug Co Ltd

See Also

Company

Help

Tools

Stocks

Korean Drug Co Ltd KOSDAQ:014570

Balance Sheet

Balance Sheet Decomposition Korean Drug Co Ltd

Balance Sheet Korean Drug Co Ltd

See Also

Company

Help

Tools

Stocks

Korean Drug Co Ltd
KOSDAQ:014570

Balance Sheet Decomposition
Korean Drug Co Ltd

Balance Sheet
Korean Drug Co Ltd